Novartis AG Cost Of Sales
Novartis AG (NVSEF) reported Cost Of Sales of $13.70 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Cost of Sales
ifrs-full:CostOfSales · last filed 2026-02-04
- Novartis AG cost of sales for the quarter ending 2025-06-30 was $3.32B, a 4.70% increase year-over-year.
- Novartis AG cost of sales for the quarter ending 2024-06-30 was $3.17B, a 5.06% decline year-over-year.
- Novartis AG cost of sales for the quarter ending 2023-06-30 was $3.34B, a 10.90% decline year-over-year.
- Novartis AG cost of sales for the quarter ending 2022-06-30 was $3.75B, a 4.16% decline year-over-year.
| Period end | Cost Of Sales 3 month | Cost Of Sales 3 month as first filed | Cost Of Sales 6 month | Cost Of Sales 6 month as first filed | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $13.70B 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $3.32B 6-K · filed 2025-07-17 | $6.55B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $12.83B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $3.17B 6-K · filed 2025-07-17 | $6.27B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $12.47B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $3.34B 6-K · filed 2024-07-18 | $4.34B 6-K · filed 2023-07-18 | $6.33B 6-K · filed 2024-07-18 | $8.27B 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $11.58B 20-F · filed 2025-01-31 | $15.49B 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $3.75B 6-K · filed 2023-07-18 | $7.61B 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $11.73B 20-F · filed 2024-01-31 | $15.87B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $3.91B 6-K · filed 2022-07-19 | $7.95B 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $15.12B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $3.43B 6-K · filed 2021-07-21 | $7.15B 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $14.43B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $3.41B 6-K · filed 2020-07-21 | $6.66B 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $14.51B 20-F · filed 2021-01-26 | $18.41B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | $3.56B 6-K · filed 2019-07-18 | $4.48B 6-K · filed 2018-07-18 | $7.01B 6-K · filed 2019-07-18 | $8.83B 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $13.63B 20-F · filed 2020-01-29 | $17.18B 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | $4.26B 6-K · filed 2018-07-18 | $8.36B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $17.52B 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $17.40B 6-K · filed 2018-01-24 |